ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

Zerhouni forms steering committee; Olden to retire.

August 1, 2003

DCCP Board Okays Concepts Of New Grants Totaling $1.4 Million Year

February 18, 1983

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989